{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20121120",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "36864",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021415s004lbl.pdf",
              "date": "20121128",
              "type": "Label"
            },
            {
              "id": "27721",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021415Orig1s004ltr.pdf",
              "date": "20121123",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20080626",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "27720",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021415s003ltr.pdf",
              "date": "20080630",
              "type": "Letter"
            },
            {
              "id": "36863",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021415s003lbl.pdf",
              "date": "20080630",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20050531",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "5306",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021415s001ltr.pdf",
              "date": "20050607",
              "type": "Letter"
            },
            {
              "id": "15413",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021415s001lbl.pdf",
              "date": "20050607",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20040727",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "application_docs": [
            {
              "id": "21643",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021415s000_MetvixiaTOC.html",
              "date": "20060321",
              "type": "Review"
            },
            {
              "id": "27719",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21415ltr.pdf",
              "date": "20040730",
              "type": "Letter"
            },
            {
              "id": "36862",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21415lbl.pdf",
              "date": "20040730",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA021415",
      "sponsor_name": "GALDERMA LABS LP",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "METVIXIA",
          "active_ingredients": [
            {
              "name": "METHYL AMINOLEVULINATE HYDROCHLORIDE",
              "strength": "EQ 16.8% BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "CREAM",
          "route": "TOPICAL",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}